These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 8643164)

  • 1. Evolution of renal injury in a chronic model of IgA immune-complex-associated nephropathy.
    Montinaro V; Aventaggiato L; Cavallo T; Rifai A
    Nephrol Dial Transplant; 1995 Nov; 10(11):2035-42. PubMed ID: 8643164
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antigen as mediator of glomerular injury in experimental IgA nephropathy.
    Montinaro V; Esparza AR; Cavallo T; Rifai A
    Lab Invest; 1991 Apr; 64(4):508-19. PubMed ID: 2016857
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Experimental IgA nephropathy. Enhanced deposition of glomerular IgA immune complex in proteinuric states.
    Chen A; Ding SL; Sheu LF; Song YB; Shieh SD; Shaio MF; Chou WY; Ho YS
    Lab Invest; 1994 May; 70(5):639-47. PubMed ID: 8196360
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of activated human mesangial cell proliferation by the natural product of Cordyceps sinensis (H1-A): an implication for treatment of IgA mesangial nephropathy.
    Lin CY; Ku FM; Kuo YC; Chen CF; Chen WP; Chen A; Shiao MS
    J Lab Clin Med; 1999 Jan; 133(1):55-63. PubMed ID: 10385482
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IgA nephropathy: lessons from an animal model, the ddY mouse.
    Tomino Y
    J Nephrol; 2008; 21(4):463-7. PubMed ID: 18651534
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-macrophage migration inhibitory factor reduces transforming growth factor-beta 1 expression in experimental IgA nephropathy.
    Leung JC; Chan LY; Tsang AW; Liu EW; Lam MF; Tang SC; Lai KN
    Nephrol Dial Transplant; 2004 Aug; 19(8):1976-85. PubMed ID: 15187193
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Experimental IgA nephropathy in mice.
    Sato M; Ideura T; Koshikawa S
    Lab Invest; 1986 Apr; 54(4):377-84. PubMed ID: 3515045
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pathogenesis of IgA nephropathy: in vitro activation of human mesangial cells by IgA immune complex leads to cytokine secretion.
    Chen A; Chen WP; Sheu LF; Lin CY
    J Pathol; 1994 Jun; 173(2):119-26. PubMed ID: 8089806
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of mesangial complement in the hematuria of experimental IgA nephropathy.
    Emancipator SN; Ovary Z; Lamm ME
    Lab Invest; 1987 Sep; 57(3):269-76. PubMed ID: 3306149
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glomerular activation of the lectin pathway of complement in IgA nephropathy is associated with more severe renal disease.
    Roos A; Rastaldi MP; Calvaresi N; Oortwijn BD; Schlagwein N; van Gijlswijk-Janssen DJ; Stahl GL; Matsushita M; Fujita T; van Kooten C; Daha MR
    J Am Soc Nephrol; 2006 Jun; 17(6):1724-34. PubMed ID: 16687629
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection and characterization of circulating and glomerular immune complexes in experimental IgA nephropathy.
    González-Cabrero J; Egido J; Barat A; González E
    Immunology; 1990 Jul; 70(3):296-302. PubMed ID: 2379938
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The kinetics of glomerular deposition of nephritogenic IgA.
    Yamaji K; Suzuki Y; Suzuki H; Satake K; Horikoshi S; Novak J; Tomino Y
    PLoS One; 2014; 9(11):e113005. PubMed ID: 25409466
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Engagement of transferrin receptor by polymeric IgA1: evidence for a positive feedback loop involving increased receptor expression and mesangial cell proliferation in IgA nephropathy.
    Moura IC; Arcos-Fajardo M; Gdoura A; Leroy V; Sadaka C; Mahlaoui N; Lepelletier Y; Vrtovsnik F; Haddad E; Benhamou M; Monteiro RC
    J Am Soc Nephrol; 2005 Sep; 16(9):2667-76. PubMed ID: 15987753
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Spatial arrangement of IgA and C3 as a prognostic indicator of IgA nephropathy.
    Muda AO; Feriozzi S; Rahimi S; Faraggiana T
    J Pathol; 1995 Oct; 177(2):201-8. PubMed ID: 7490687
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Experimental IgA-IgG nephropathy induced by a viral respiratory pathogen. Dependence on antigen form and immune status.
    Jessen RH; Emancipator SN; Jacobs GH; Nedrud JG
    Lab Invest; 1992 Sep; 67(3):379-86. PubMed ID: 1328763
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monomeric immunoglobulin A protects glomerulus against polymeric immunoglobulin A immune complex in experimental immunoglobulin A nephropathy.
    Chen A; Sheu LF; Ding SL; Lee WH
    Lab Invest; 1996 Apr; 74(4):737-46. PubMed ID: 8606484
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Histology and immunohistology of IgA nephropathy.
    Haas M
    J Nephrol; 2005; 18(6):676-80. PubMed ID: 16358224
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oxidative stress in IgA nephropathy.
    Coppo R; Camilla R; Amore A; Peruzzi L
    Nephron Clin Pract; 2010; 116(3):c196-8, discussion c199. PubMed ID: 20606479
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New insights in the pathogenesis of IgA nephropathy.
    Monteiro RC
    Nefrologia; 2005; 25 Suppl 2():82-6. PubMed ID: 16050408
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Complement depletion abolishes IgA-mediated glomerular inflammation in rats.
    Stad RK; van Gijlswijk-Janssen DJ; van Es LA; Daha MR
    Exp Nephrol; 1994; 2(3):182-9. PubMed ID: 7922271
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.